Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transurethral Resection of the Bladder”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Not applicableLooking for participantsNCT07463963
What this trial is testing

Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial

Who this might be right for
Bladder CancerTransurethral Resection of the BladderUrinary Tract Infection Bacterial
Poitiers University Hospital 2,600
Not applicableUnknownNCT05027412
What this trial is testing

En Bloc TURBT With Collins Loop vs Conventional TURBT

Who this might be right for
Bladder CancerBladder NeoplasmBladder Urothelial Carcinoma+2 more
Hospital Universitario de Fuenlabrada 80
Not applicableUnknownNCT06217055
What this trial is testing

Comparison of Remimazolam-based MAC With Inhalation General Anesthesia Under the Guidance of an ANI Monitor During TURB

Who this might be right for
Patients Undergoing Transurethral Resection of Bladder
Yonsei University 46
Not applicableNot Yet RecruitingNCT07203989
What this trial is testing

The Effect of Video Calls With Family Members During Operating Room Waiting on Stress, Anxiety, and Surgical Fear in Patients Undergoing Transurethral Resection of Bladder Tumor

Who this might be right for
Bladder Tumor (TURBT)Bladder (Urothelial, Transitional Cell) Cancer
Bitlis Eren University 124
Not applicableLooking for participantsNCT07036731
What this trial is testing

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

Who this might be right for
Non Muscle Invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 428
Not applicableStudy completedNCT07259798
What this trial is testing

Histopathological Findings in En-Bloc vs Conventional Transurethral Resection of Bladder Tumors.

Who this might be right for
Urinary Bladder Cancer
Ain Shams University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808216
What this trial is testing

Toripalimab Combined With Intravesical Gemcitabine as Adjuvant Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer After TURBT

Who this might be right for
Non Muscle Invasive Bladder Cancer
Tianjin First Central Hospital 54
Not applicableStudy completedNCT07642102
What this trial is testing

Evaluation of the Role of Early Second Look TURBT in Management of High Risk Non Muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Transurethral Resection of Bladder Tumor
Ain Shams University 70
Not applicableUnknownNCT02534623
What this trial is testing

Postoperative Quality of Recovery After Transurethral Resection of the Bladder

Who this might be right for
Urinary Bladder NeoplasmsTransurethral Resection of the BladderPostoperative Recovery
General Hospital Zadar 70
Not applicableStudy completedNCT04900259
What this trial is testing

The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations

Who this might be right for
Bladder CancerCovid19
Ankara Training and Research Hospital 183
Large-scale testing (Phase 3)UnknownNCT02951078
What this trial is testing

Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 172
Not applicableStudy completedNCT05314582
What this trial is testing

Anticoagulant/Antiaggregant Use and Postoperative Bleeding Risk in Patients With Bladder Tumor and Benign Prostatic Hyperplasia

Who this might be right for
HematuriaRetention, UrinaryOperative Bleeding+1 more
Bezmialem Vakif University 500
Large-scale testing (Phase 3)Study completedNCT00461591
What this trial is testing

Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611)

Who this might be right for
Bladder Cancer
Spectrum Pharmaceuticals, Inc 802
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07142200
What this trial is testing

A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral Resection

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
RenJi Hospital 45
Testing effectiveness (Phase 2)Study completedNCT00002919
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer

Who this might be right for
Bladder Cancer
Memorial Sloan Kettering Cancer Center 30
Large-scale testing (Phase 3)UnknownNCT00816075
What this trial is testing

Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection

Who this might be right for
Recurrent Superficial Bladder CancerDistilled Water
Bozyaka Training and Research Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT00003642
What this trial is testing

Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer

Who this might be right for
Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 43
Large-scale testing (Phase 3)Active Not RecruitingNCT06111235
What this trial is testing

Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

Who this might be right for
Non Muscle Invasive Bladder CancerUrologic CancerBladder Cancer+1 more
CG Oncology, Inc. 367
Testing effectiveness (Phase 2)Study completedNCT00191711
What this trial is testing

Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.

Who this might be right for
Superficial Bladder Cancer
Eli Lilly and Company 43
Not applicableStudy completedNCT07481123
What this trial is testing

COMPARISON OF OBTURATOR NERVE BLOCK TECHNIQUES IN TURBT

Who this might be right for
Bladder Cancer
Yavuz Saygılı 60
Next Page